Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


Leave your comfort zone if you aim for success

Peter Carmeliet is the director of the VIB’s Vesalius Research Center (VRC) and a leading Belgian scientist who pushes the boundaries in interdisc…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…

POPULAR TAGS

Janssen to team up with UGent and UZ Gent in industry-academia collaboration

Written by ALB on in the category news with the tags , .


Janssen Pharmaceutica have signed a renewal of the innovation charter with Ghent University (UGent) and Ghent University Hospital (UZ Gent). The move is part of an initiative to share more knowledge and expertise between industry and academia, stimulating scientific progress and reaching patients faster than ever before.

UGent and UZ Gent have been building a close collaboration with Janssen Pharmaceutica in recent years. The partners are now expanding this collaboration to a range of new areas, including big data, clinical trials, cancer research, nanomedicine and smart production methods.

The overlapping interest areas of the different organizations have produced ten key innovation areas, with the primary four consisting of:

  • Taking innovative approaches to setting up and running clinical trials
  • Unraveling the mechanism of action of diseases and developing inhibitors and vaccines for respiratory infections, viral hepatitis, HIV and Ebola
  • Expanding a biobank for scientific research
  • Developing innovative pharmaceutical production technologies

This collaboration is part of an important trend and is characteristic for a changing climate in industry and academia. Pharmaceutical companies are increasingly wanting to invest in external innovation and work with partner organizations. Through collaborations, such as the one between Janssen and UGent/UZ Gent, it is easier for all parties to jointly find solutions to complex medical challenges and mobilize the talent needed to achieve these healthcare goals. Both partners, industry and academic, are here openly acknowledging that they can reach their final goal, better patient care, faster and more effectively by working together.

Prof. Rik Van de Walle, Rector at UGent, believes this move is extremely important. "This collaboration is a game-changer - it's not just an exchange program; we are aiming for a long-term joint innovative approach with one goal: making patients better."

"We want to exchange scientific knowledge and talent in areas with significant potential for finding new ways of treating, intercepting and preventing diseases. Joining forces with renowned universities such as UGent and university hospitals such as UZ Gent to innovate in a range of areas allows us to make a meaningful difference and continue to work towards medical innovation in Belgium, Europe and the world,” says Stef Heylen, Managing Director, Janssen Pharmaceutica.

"This renewed collaboration agreement is a sign of Janssen's commitment to working with others to find solutions to the most complex medical challenges and to mobilizing the best talent to achieve this goal", says Sonja Willems, Managing Director of Janssen Benelux.

Read more about: , .

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


Leave your comfort zone if you aim for success

Peter Carmeliet is the director of the VIB’s Vesalius Research Center (VRC) and a leading Belgian scientist who pushes the boundaries in interdisc…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Janssen V-Bio Ventures XpandInnovation Flanders.bio Turnstone UGent Itera Life Science KU Leuven Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.